The journey was started through the formation of a proprietorship firm under the dynamic guidance of Mr. M. A. Hassan, present Chairman & Managing Director of the company. It was a modest start with the introduction of a few products in oral liquid & tablet form. The journey continued through pains & pleasures, through shines & showers...
The new manufacturing plant was built at Shampur-Kadamtali I/A, 10 km from central Dhaka, with highly sophisticated and advanced facilities.
Production line was diversified with the addition of cream and ointment in the portfolio.
Company started exporting to foreign countries; Vietnam was the first country to export.
Sterile product manufacturing facility was established & sterile ophthalmic products were introduced in the market. Moreover, as the first Pharmaceutical Company of Bangladesh, Aristopharma exported medicines to Hong Kong - one of the most developed countries of Asia.
The diversification rolled on- parenteral dosage forms like Ceftriaxone, Cefuroxime injections etc. were introduced.
Company attained ISO 9001:2000 certificate as a recognition to its Quality Management System. Company also touched another landmark in export. It crossed the continental boundary and started export to Ukraine of East Europe.
Export started to Mauritius of Africa. In the same year Aristovision became No. 1 in ophthalmic market of Bangladesh and Aristopharma as a whole entered the top 10 chart of Bangladesh Pharmaceutical Market.
Signed agreement with APC, Australia to set up its 3rd plant at Gachha, Tongi
The new expansion building of factory started operation with around 66000 sq. ft. floor area and with the facilities for inhalers, suppositories, lyophilized injections, pre-filled syringes, insulin & other biotech products etc.
The company celebrated Silver Jubilee of serving ailing humanity for 25 years. On this occasion company declared special benefits for its employees and arranged different programs for doctors, employees and for other stakeholders.
The construction work of its 3rd plant at Gachha, Tongi is progressing in full swing. The plant once completed would open up export opportunities to USA & Europe market. Apart from solid dosage forms the plant would help us to manufacture amino acid, hormone, vaccines, anti-cancer products etc.
Company achieved the capacity to manufacture 5 high-tech products- Erythropoietin Injection, Enoxaparin Prefilled Syringe, Inhalers, Insulin Injections and Lyophilized injections as the first & only company in Bangladesh.
The construction work of dedicated cephalosporin plant at Gachha, Tongi is fully completed and soon it would be inspected by Drugs Administration of Bangladesh for approval of its operation.
The company received manufacturing license for its Gazipur plant for biological products from Directorate General of Drug Administration of Bangladesh. This plant is built as per WHO cGMP and UK MHRA guidelines.
© 2018. Aristopharma Ltd. All rights reserved.
Site by DIGITA iNTERACTIVE